Tolterodine: A safe and effective treatment for older patients with overactive bladder

被引：0
|
作者：
Kausar, SA [1 ]
机构：
[1] Princess Margaret Hosp, Dept Med, Swindon, Wilts, England
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2002年 / 50卷 / 04期
关键词：
D O I：
10.1046/j.1532-5415.2002.50179.x
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：775 / 775
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF TOLTERODINE AS TREATMENT FOR OVERACTIVE BLADDER (OAB) IN ADULT MEXICAN PATIENTS
    Arreola-Ornelas, H.
    Rosado-Buzzo, A.
    Garcia-Mollinedo, M.
    Camacho-Cordero, L.
    Mucino-Ortega, E.
    Mould-Quevedo, J. F.
    Galindo-Suarez, R. M.
    VALUE IN HEALTH, 2011, 14 (03) : A76 - A76
  • [42] Efficacy of tolterodine in children with overactive bladder
    Koc, Basak
    Canpolat, Nur
    Adaletli, Ibrahim
    Sever, Lale
    Emir, Haluk
    Caliskan, Salim
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2020, 55 (03): : 284 - 289
  • [43] Onset of efficacy of tolterodine extended release in patients with overactive bladder
    Sussman, David O.
    Kraus, Stephen R.
    Carlsson, Martin
    Guan, Zhonghong
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 777 - 781
  • [44] Propiverine versus tolterodine:: Efficacy and tolerability in patients with overactive bladder
    Jünemann, KP
    Halaska, M
    Rittstein, T
    Mürtz, G
    Schnabel, F
    Brünjes, R
    Nurkiewicz, W
    EUROPEAN UROLOGY, 2005, 48 (03) : 478 - 482
  • [45] SAFE AND EFFECTIVE TREATMENT OF OVERACTIVE BLADDER WITH A MINIATURIZED RECHARGEABLE SACRAL NEUROMODULATION SYSTEM
    De Wachter, Stefan
    Blok, Bertil
    Van Kerrebroeck, Philip
    Rufion, Alain
    Van der Aa, Frank
    Verbe, Marie Aimee Perrouin
    Jairam, Ranjana
    Elneil, Suzy
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S563 - S564
  • [46] Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder
    Sun, Fengying
    Sui, Cheng
    Zhou, Yulin
    Liu, Ximing
    Shi, Yanan
    Wu, Yi
    Li, Youxin
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 454 (01) : 532 - 538
  • [47] Benefit-Risk Assessment of Tolterodine in the Treatment of Overactive Bladder in Adults
    Alan D. Garely
    Lara Burrows
    Drug Safety, 2004, 27 : 1043 - 1057
  • [48] Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine
    R. A. Appell
    P. Abrams
    H. P. Drutz
    P. E. V. A. Van Kerrebroeck
    R. Millard
    A. Wein
    World Journal of Urology, 2001, 19 : 141 - 147
  • [49] The impact of tolterodine treatment on self-reported quality of life in patients with overactive bladder.
    Stevic, MO
    Bailey, KL
    Mayl, B
    Grace, S
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (04) : S159 - S159
  • [50] Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine
    Kobelt, G
    Kirchberger, I
    Malone-Lee, J
    BJU INTERNATIONAL, 1999, 83 (06) : 583 - 590
12345